Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-021614

CEO and CFO bought 10,600 shares at $8.43 ($89,358)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-11-07 Purchase +10,600 $8.43 $89,358 5,583,502 D: show line 1 in the form
Open-market purchases · 10,600 sh · avg $8.43 · $89,358
Loading xslF345X05/ownership.xml…